Former U.S. President Joe Biden, aged 82, has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones. The diagnosis was confirmed following a routine physical examination after Biden experienced increasing urinary symptoms. His medical team reported that the cancer is hormone-sensitive, which may allow for effective management. Biden and his family are currently reviewing treatment options with his physician.
The cancer is characterized by a Gleason score of 9 (Grade Group 5), indicating a high-grade and aggressive form of prostate cancer. Despite its severity, the hormone-sensitive nature of the disease offers a potential pathway for treatment.
In 2023, Biden had a basal cell carcinoma lesion removed from his chest during a routine physical examination. This type of skin cancer does not tend to spread and was successfully treated without further complications.
The news of Biden’s diagnosis has prompted an outpouring of support from political figures across the spectrum. Former President Donald Trump expressed his sympathy, stating that he and First Lady Melania Trump were “saddened” by the news and wished the Bidens a “fast and successful recovery” . Vice President Kamala Harris also offered her support, describing Biden as a “fighter” who will face this challenge with strength and resilience.
Biden’s administration had previously launched the “Cancer Moonshot” initiative, aiming to accelerate cancer research and reduce cancer death rates. The initiative was inspired by the loss of his son, Beau Biden, to brain cancer in 2015. As Biden navigates this personal health challenge, his experience underscores the importance of regular health screenings and early detection in managing serious health conditions.
